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Azo dyes represent the major class of dyestuffs. They are
metabolised to the corresponding amines by liver enzymes
and the intestinal microflora following incorporation by
both experimental animals and humans. For safety
evaluation of the dermal exposure of consumers to azo
dyes from wearing coloured textiles, a possible cleavage of
azo dyes by the skin microflora should be considered
since, in contrast to many dyes, aromatic amines are easily
absorbed by the skin. A method for measuring the ability of
human skin flora to reduce azo dyes was established. In a
standard experiment, 361011 cells of a culture of
Staphylococcus aureus were incubated in synthetic sweat
(pH 6.8, final volume 20 mL) at 288C for 24 h with Direct
Blue 14 (C.I. 23850, DB 14). The reaction products were
extracted and analysed using HPLC. The reduction
product o-tolidine (3,3’-dimethylbenzidine, OT) could
indeed be detected showing that the strain used was able
to metabolise DB 14 to the corresponding aromatic amine.
In addition to OT, two further metabolites of DB 14 were
detected. Using mass spectrometry they were identified as
3,3’-dimethyl-4-amino-4’-hydroxybiphenyl and 3,3’-di-
methyl-4-aminobiphenyl. The ability to cleave azo dyes
seems to be widely distributed among human skin
bacteria, as, under these in vitro conditions, bacteria
isolated from healthy human skin and human skin
bacteria from strain collections also exhibited azo
reductase activity. Further studies are in progress in order
to include additional azo dyes and coloured textiles. At the
moment, the meaning of the results with regard to
consumer health cannot be finally assessed.
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Introduction
Azo colorants are the most important textile color-
ants which are divided, according to their solubi-
lity, into azo dyes (soluble) and azo pigments
(insoluble). They are synthesised from arylamines
by diazotation and coupling and are characterised
by the azo group (R-N=N-R). It is well-known that
soluble azo dyes when incorporated into the body
are split into the corresponding aromatic amines by
liver enzymes and the intestinal microflora.1,2
Several aromatic amines are, or are suspected to
be, carcinogenic. It has therefore been stated that
‘all azo colorants whose metabolism can liberate a
carcinogenic arylamine are suspected of having
carcinogenic potential’.3 In Germany, clothing
textiles containing azo dyes that may release certain
aromatic amines may not be marketed according to
the Regulations on Specific Commodities (under the
Foods Act).4 In the past, azo reductase activity has
been reported for the mammalian intestinal micro-
flora and mammalian liver enzymes.1,2 An analo-
gous activity of skin bacteria is not known. For
safety evaluation of the dermal exposure of con-
sumers to azo dyes from wearing coloured textiles,
it is relevant to consider a possible cleavage of azo
dyes by the skin microflora since, in contrast to
many dyes, aromatic amines are easily absorbed via
the skin.5
In this study, the capability of human skin
bacteria to metabolise azo dyes was investigated
by measuring the reduction to the corresponding
amines. As model compound Direct Blue 14 (DB 14)
was used. DB 14 is a typical member of the group of
direct dyes which are defined as water-soluble dyes
capable of directly dyeing cellulose fibres. In a
review of 1975 its use for dyeing textiles and leather
was addressed.6 More recent data are not available.
A standardised assay was established to determine
the reductive capacity of skin bacteria using
collections of bacterial strains and freshly isolated
ones from healthy human skin.
Materials and methods
Substances
Direct Blue 14 (Trypan Blue, C.I. 23850, DB 14) and
o-tolidine (3,3’-dimethylbenzidine, OT) were pur-
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chased from Aldrich Inc. Since it was reported that
OT is a contaminant of DB 14 the content of OT in
DB 14 was investigated using HPLC and was found
to be less than 5 p.p.m.
Chemical azo cleavage
Chemical splitting of the dye was performed
according to the official method by reduction with
sodium dithionate in a citrate-buffered aqueous
solution (pH 6) at 708C in a closed vessel.7 The
amines released in the process of reductive cleavage
were transferred to a t-butylmethyl-ether phase by
means of liquid-liquid extraction using Extrelut1 20
columns (Merck). The eluate was concentrated to
1 mL in vacuo. The remaining of the solvent was
removed by nitrogen. The residue was redissolved
in 500 mL methanol and directly analysed by HPLC.
Bacteria
The following bacterial strains were used (strain
numbers are those of VLSF, Institut fu¨r Ga¨rungsge-
werbe und Biotechnologie, Berlin, FRG): Micro-
coccus luteus (Mi-0702), Micrococcus roseus (Mi-
0401), Micrococcus varians (Mi-0503), Staphylo-
coccus aureus (St-0411), Staphylococcus epidermi-
dis (St-0201). Additional strains used were St.
aureus DSM 1104, St. epidermis DSM 1798, and
St. epidermis DSM 22044. Strain Staphylococcus
aureus TU 5 – 3 (previously designated as St.
epidermis) was used to establish the standardised
assay.8
Skin bacteria isolates were taken from the left
bend of the elbow of six healthy individuals. There
was a time interval of at least 24 h between the last
washing and the time of collection of bacteria.
Bacteria were grown and subcultured on Standard I
Agar (Merck, Germany). Morphologically different
types of colonies were identified and one colony of
each type was randomly picked. Pure cultures were
obtained by repeated restreaking. Isolates A to E
were used in the subsequent assays. The isolates
were typed according to Bergey’s Manual of
Systematic Bacteriology.9 Strains were stored on
nutrient Agar slopes at 48C or in nutrient broth plus
17% glycerol at 7708C.
Culture conditions
The strains were grown in a preculture (20 mL
Standard I broth, Merck No. 7782) at 288C for 62 h
on a reciprocal shaker (120 r.p.m.). One mL of the
bacterial solution was inoculated into 120 mL
Standard-I-Medium for the main culture which was
incubated at 288c for 48 h. If required, induction was
achieved by adding DB 14 (1 mg/mL) to the main
culture. In a typical experiment about 361011
bacteria (about 400 OD610) corresponding to 60 mL
grown culture, were used per assay. Cells of the
stationary phase (48 h growth) were harvested by
centrifugation and resuspended in 20 mL of freshly
prepared sweat simulant. Sweat simulant was
prepared by dissolving 0.5 g L-histidine-monohy-
drochloride-1-hydrate, 5 g sodium chloride and
2.2 g sodium dihydrogenphosphate-2-hydrate in
1 L distilled water and adjusting the pH to 6.8. The
dye was added to the bacterial suspension in sweat
simulant (7 mg DB 14 in a standard assay) and the
mixture was incubated at 288C for 24 h under
shaking (frequency 40 r.p.m.) in a water bath. The
reaction was stopped by cooling on ice, the pH was
adjusted to 11 with 10 N NaOH, and the amines were
eluted on Extrelut1 colunmns with 4620 mL t-
butylmethyl-ether. The t-butylmethylether extract
was then treated as described above.
HPLC separation
HPLS separation was achieved using the Beckman
System Gold. Stationary phase: LiChrosorb 60 RP-
select B (5 mm); column: 25064.6 mm, (M&W,
Berlin, Art.-Nr. 254671005); Eluent 1/2: Methanol
LiChrosolv/0.575 g ammonium hydrogenphos-
phate/L, 0.7 g disodium hydrogenphosphate/L, pH
6.9; Elution: Eluent 1/eluent 2 (60/40 V/V), flow
1.0 mL/min; oven temperature: 408C, injection
volume 10 or 50 mL; Detector: Diode array detector
(DAD), wavelengths: 207 nm and 280 nm.
The detection limit of OT was 29 ng (136 pmol)
per chromatographic run (50 mL of 500 mL injected)
corresponding to 1.4 nmol OT per assay. The
recovery rate was determined by adding various
amounts of OT to the mixture (sweat simulant with
bacteria without DB 14) after the 24 h incubation
period. Depending on the amount added, the
recovery rate was 76 to 93%. Under these condi-
tions, the recovery rate from five assay vials
containing the same amount of OT (4.3 mg) was
88+4%. Nevertheless, 3,3’-dichlorobenzidine was
used as an internal standard in most of the
experiments.
Capillary gas chromatography/mass spectrometry
Apparatus: HP 5890A, coupled with Finnigan SSQ;
GC-column: J & W fused silica capillary column DB-
5; dimension 50 m60.32 mm, film thickness
0.1 mm; injection volume 1 mL, on column tempera-
ture programme: 08C, 1 min, 108C/min, 2408C, 38C/
min, 2908C, 10 min, gas: helium; EI parameter:
Transline temperature 2808C, ion source 1508C,
ionisation energy: 70 eV, source pressure ca.
161076 Torr, cyclic scan 0.9 s, mass area 45 – 350;
CI parameter: Reactant gas methane, source pres-
sure 7,000 Torr, mass area 80 – 350.
Results
Chemical reduction of DB 14
According to the above-mentioned method DB 14
was reduced with sodium dithionate. The reaction
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products were extracted and isolated as described
above. The expected cleavage product OT (see
Figure 1) was identified on the basis of the retention
time (7.17 min) and the u.v. spectrum as compared
to an authentic standard.
Reaction of DB 14 with St. aureus TU 5 – 3
Seven mg (7.3 mmol) DB 14 was incubated with
about 361011 cells of St. aureus TU 5 – 3 for 24 h.
This strain which had been deposited in the
collection as St. epidermidis was chosen as a typical
representative of the major class of human skin
bacteria.10 The strain was reclassified as St. aureus
during this study. The reaction products were
extracted and isolated as described above. The
HPLC separation of the reaction product is shown
in Figure 2. In addition to OT, two further u.v.-
absorbing compounds were detected during HPLC
separation (retention times 8.09 and 19.66 min,
respectively). No reaction products were seen when
DB 14 was incubated in sweat simulant under
standard conditions in the absence of bacteria.
Likewise reaction products were absent in the
bacteria suspension when no azo dye had been
included in the reaction mixture.
Similarly, three cleavage products were detected
in a total ion current chromatogram by GC/MS
analysis of the reaction products (see Figure 3).
Using EI- and CI-mass spectrometry, the compound
at the HPLC retention time 8.09 min was identified
as 3,3’ - dimethyl - 4 - amino - 4’-hydroxybiphenyl
(DAHBP) whereas the compound at retention time
19.66 min was assigned the structure of 3,3’-
dimethyl-4-aminobiphenyl (DABP) (see Figures 4
and 5).
The CI mass spectrum of DAHBP indicates a
molecular mass of 213 and the existence of one
nitrogen atom (quasi molecular peaks M+H+=m/z
Figure 1 Azo cleavage of DB 14 and formation of OT
Figure 2 HPLC separation of the reaction product following incubation of DB 14 with St. aureus TU5-3 (standard conditions)
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214; M+28=m/z 242). Furthermore, the difference of
m/z 17 between the fragment ions m/z 169 and m/z
152 may be assigned to a hydroxyl group. This
group is additionally indicated by fragments m/z
107 and m/z 106 formed by phenyl cleavage. In the
case of DABP, the loss of the amino group is
indicated by the molecular peak m/z 197.
An additional reaction product was found when
the bacteria-dye mixture was incubated under
anaerobic and inductive conditions for 72 h (mole-
cular peak m/z 239, quasi molecular peaks:
M+H+=m/z 240; M+C2H4+=m/z 268). The spectra
indicate an N-acetylated derivative, 3,3’-dimethyl-
4-acetylaminobiphenyl.
Quantitative aspects
OT as the expected product of the reduction of DB
14 was quantified in the standard assay and in
assays using varying experimental parameters
(Table 1). Depending on the assay conditions, 3.2
to 26.0 mg (15 to 123 nmol) OT were formed
following incubation of either 7 mg (7.3 mmol) DB
14 which resembles a reduction rate of 0.2 to 1.7%.
Inclusion of the azo dye in the culture medium
(‘inductive conditions’) resulted in a slight increase
in the reaction product (+15% as compared to the
standard conditions). A much more significant
effect (+90%) was seen when the cells were
harvested in a different growth phase (late log to
early stat phase versus late stat phase under
standard conditions). The increase in OT formation
using a high cell concentration was non-linear: a
2.6-fold increase in the number of bacterial cells per
assay resulted in a 8.1-fold increase in the amount of
OT formed (Table 1).
Due to the lack of standards for the metabolites
DABP and DAHBP which are by-products in the
reaction, the relative amounts of OT, DABP, and
DAHBP were quantified based on the peak areas
measured in the HPLC analyses (Table 2). The data
have shown that the relative amount of OT is
dependent on the assay conditions and that the
amount of OT formed might not be fully representa-
tive of the total metabolic activity of the cells.
DB 14-reductive capacity of normal skin flora
Additional strains representative of human skin
flora or strains freshly isolated from healthy
individuals were assayed for their reductive capa-
city using DB 14 as a substrate. The cells were
grown under standard conditions and OT as the
primary reaction product was quantified (Table 3).
Interestingly, most of the strains analysed exhibited
reductive activity and produced the characteristic
cleavage product, OT.
Discussion
Azo dyes are important colorants. More than 2000
of these substances have been synthesised, and
about 500 of them are based on carcinogenic
aromatic amines.11,12 Following incorporation they
are metabolised to the corresponding aromatic
amines. In the mammalian liver, azo compounds
are metabolised by cytosolic and microsomal
Figure 3 Total ion current chromatogram of GC/MS analysis of the reaction product following incubation of DB 14 with St. aureus
TU5-3 (standard conditions)
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enzymes, e.g. by reductive cleavage to the amines.
The intestinal microflora plays an even more
important role.1,2 It was found that bacterial strains
in human faeces are capable of cleaving azo dyes.13
It has been known for decades that certain azo dyes,
which are split into carcinogenic aromatic amines
like benzidine, are carcinogenic in both experi-
mental animals and humans.14
The mutagenicity of benzidine and benzidine-
congener dyes is well documented. A modified
Salmonella assay was developed and DB 14 was
found to be mutagenic under these conditions.15,16
The significance of azo-reduction in the mutagen-
esis and carcinogenesis of azo dyes was reviewed
earlier.17 Additionally, for DB 14 reproductive
toxicity is worth mentioning.18
The reductive cleavage of azo dyes during
percutaneous absorption was investigated in vitro
using skin from mice, guinea pigs, and humans. All
species tested were capable of reductive cleavage of
Figure 4 EI and CI mass spectra of DAHBP
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the dyes.19 Following epicutaneous treatment of rats
in vivo with a 14C-labelled azo dye, a significant
amount of radioactivity was found in urine and
faeces. It was speculated that azo cleavage resulting
in the formation of aromatic amines is mediated via
the microflora of the rat skin.20
The microflora of the human skin is variable with
regard to bacterial strains and species. However,
staphylococci and micrococci represent major
Figure 5 EI and CI mass spectra of DABP
Table 1 Formation of OT after incubation with S. aureus TU5-3
cells in sweat simulanta
Assay condition OT (mg per assay)
Standard assay
Standard assay, inductive conditions
Cells from early-stationary growth phase
Concentrated cell suspension (2.66)
3.2
3.7
6.1
26.0
aData represent mean values of at least two independent
experiments
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groups of bacteria inhabiting the human skin. The
quantity varies extremely depending on age and site
(66102 to 26106 per cm2).9,21
In our experiments using skin bacteria, cleavage
of the azo dye DB 14 to the corresponding aromatic
amine OT was proved. Following incubation using
standard conditions (24 h incubation period),
further metabolites were detected and identified as
deaminated (DABP) and deaminated/hydroxylated
(DAHBP) derivatives of OT, respectively. An addi-
tional reaction product was found following an
incubation period of 72 h which was identified as a
deaminated/N-acetylated derivative of OT. Similar
microbially-produced metabolites (deaminated and
N-acetylated derivatives) were found by Manning et
al. following incubation of a culture derived from
human faeces with the benzidine-based azo dye
Direct Black 38. The authors demonstrated that the
mutagenicity was increased by the human intestinal
microflora.22,23
The wearing of textiles is assumed to be the
most widespread exposure to colorants, but the
exposure by this route was estimated to be less
than 1 mg per individual per day.24 The release
rate of dyes from coloured textiles was measured,
and from these data, the extent of exposure was
calculated to be 1 – 10 mg per kg body weight.25,26
However, in the case of garments not having been
dyed according to state-of-the-art technology one
has to assume much higher release rates and
exposures.
Previously, it was argued that, due to the low
degree of percutaneous absorption of certain dyes,
external exposure to dyes may not pose a significant
risk to the consumer. The results of our experi-
ments, however, clearly demonstrate the ability of
bacteria of the human skin to metabolise azo dyes to
aromatic amines which are known to easily pene-
trate the skin. In this study, just a small portion of
the azo dye present in the assay was split.
Presumably, the formation rate is limited by the
number of bacteria of the assay and their metabolic
capacity. Additional experiments including co-
loured textiles and lipophilic dyes are in progress
to elucidate the quantitative aspects in more detail.
It is worth mentioning that, basically, conclusions
drawn from in vitro studies to the risk in vivo are of
limited value. So far, the risk for the consumer from
wearing textiles dyed with such colorants cannot be
finally assessed.
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Table 2 Relative amounts of OT, DABP, and DAHBP after
incubation of DB 14 with St. aureus TU5-3 cells in sweat
simulanta
Assay condition
Area
of OT
(relative)
Area of
DABP
(relative)
Area of
DAHBP
(relative)
Standard assay
Cells from early-stationary
growth phase
Concentrated cell suspension
(2.66)
71 (1.0)
159 (1.0)
390 (1.0)
152 (2.1)
214 (1.4)
296 (0.8)
91 (1.3)
118 (0.7)
156 (0.4)
aData from one representative experiment
Table 3 Quantification of OT after incubation of DB 14 with
cells of different bacterial strainsa
Strain/
Isolate Name
o-Tolidine
(mg/assay)
St-0201
St-0411
Mi-0702
Mi-0401
Mi-0503
DSM 1798
DSM 22044
DSM 1104
Isolate A
(yellow I)
Isolate B
(white)
Isolate C
(beige)
Isolate D
(orange)
Isolate E
(yellow II)
Staphylococcus epidermidis
Staphylococcus aureus
Micrococcus luteus
Micrococcus roseus
Micrococcus varians
Staphylococcus epidermidis
Staphylococcus epidermidis
Staphylococcus aureus
Micrococcus spec.
Coagulase-negative
Staphylococcus spec.
Coagulase-negative
Micrococcus spec.
Coagulase-negative
n.d.
Coagulase-negative
n.d.
Coagulase-negative
6.1
10.4
29.8
14.8
2.9
0.0
6.6
0.0
6.4
13.1b
0.4b
0.5a
0.6
0.0
aData represent mean values of at least two independent
experiments; bgrown under inductive conditions
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